UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Patient‐Derived Organoids from Colorectal Cancer with Paired Liver Metastasis Reveal Tumor Heterogeneity and Predict Response to Chemotherapy

Advanced science, 2022-11, Vol.9 (31), p.e2204097-n/a

2022

Volltextzugriff (PDF)

Establishment of patient‐derived organoids for guiding personalized therapies in breast cancer patients

International journal of cancer, 2024-07, Vol.155 (2), p.324-338

2024

Volltextzugriff (PDF)

The lncRNA ‘UCA1’ modulates the response to chemotherapy of ovarian cancer through direct binding to miR‐27a‐5p and control of UBE2N levels

Molecular oncology, 2021-12, Vol.15 (12), p.3659-3678

2021

Volltextzugriff (PDF)

Patient‐derived organoids as a preclinical platform for precision medicine in colorectal cancer

Molecular oncology, 2022-06, Vol.16 (12), p.2396-2412

2022

Volltextzugriff (PDF)

Clinical efficacy of tumor organoid‐guided cancer therapy for locally advanced unresectable or metastatic breast cancer

International journal of cancer, 2024-08, Vol.155 (4), p.697-709

2024

Volltextzugriff (PDF)

Patient‐Derived Organoids Can Guide Personalized‐Therapies for Patients with Advanced Breast Cancer

Advanced science, 2021-11, Vol.8 (22), p.e2101176-n/a

2021

Volltextzugriff (PDF)

A T Cell‐Engaging Tumor Organoid Platform for Pancreatic Cancer Immunotherapy

Advanced science, 2023-08, Vol.10 (23), p.e2300548-n/a

2023

Volltextzugriff (PDF)

Microfluidic Organoid Cultures Derived from Pancreatic Cancer Biopsies for Personalized Testing of Chemotherapy and Immunotherapy

Advanced science, 2024-02, Vol.11 (5), p.e2303088-n/a

2024

Volltextzugriff (PDF)

Patient‐Derived Organoids as Therapy Screening Platforms in Cancer Patients

Advanced healthcare materials, 2024-08, Vol.13 (21), p.e2302331-n/a

2024

Volltextzugriff (PDF)

Glutamine metabolism prognostic index predicts tumour microenvironment characteristics and therapeutic efficacy in ovarian cancer

Journal of cellular and molecular medicine, 2024-04, Vol.28 (7), p.e18198-n/a

2024

Volltextzugriff (PDF)

Modelling the tumor immune microenvironment for precision immunotherapy

Clinical & translational immunology, 2022, Vol.11 (6), p.e1400-n/a

2022

Volltextzugriff (PDF)

Genomic characteristics and drug screening among organoids derived from non‐small cell lung cancer patients

Thoracic cancer, 2020-08, Vol.11 (8), p.2279-2290

2020

Volltextzugriff (PDF)

Clinical outcomes of EGFR+/METamp+ vs. EGFR+/METamp‐ untreated patients with advanced non‐small cell lung cancer

Thoracic cancer, 2022-06, Vol.13 (11), p.1619-1630

2022

Volltextzugriff (PDF)

Enhanced Protein Damage Clearance Induces Broad Drug Resistance in Multitype of Cancers Revealed by an Evolution Drug‐Resistant Model and Genome‐Wide siRNA Screening

Advanced science, 2020-12, Vol.7 (23), p.2001914-n/a

2020

Volltextzugriff (PDF)

Rescue of p53 functions by in vitro‐transcribed mRNA impedes the growth of high‐grade serous ovarian cancer

Cancer communications (London, England), 2024-01, Vol.44 (1), p.101-126

2024

Volltextzugriff (PDF)

Preclinical patient‐derived modeling of castration‐resistant prostate cancer facilitates individualized assessment of homologous recombination repair deficient disease

Molecular oncology, 2023-06, Vol.17 (6), p.1129-1147

2023

Volltextzugriff (PDF)

Patient‐derived organoid culture in epithelial ovarian cancers—Techniques, applications, and future perspectives

Cancer medicine (Malden, MA), 2023-10, Vol.12 (19), p.19714-19731

2023

Volltextzugriff (PDF)

Recent advances in patient‐derived tumor organoids for reconstructing TME of head and neck cancer

Journal of oral pathology & medicine, 2024-04, Vol.53 (4), p.238-245

2024

Volltextzugriff (PDF)

Organoid technology in cancer precision medicine

Cancer letters, 2019-08, Vol.457, p.20-27

2019

Volltextzugriff (PDF)

Butyrate enhances the efficacy of radiotherapy via FOXO3A in colorectal cancer patient‑derived organoids

International journal of oncology, 2020-12, Vol.57 (6), p.1307-1318

2020

Volltextzugriff (PDF)

The functional and clinical roles of liquid biopsy in patient-derived models

Journal of hematology and oncology, 2023-04, Vol.16 (1), p.36-36, Article 36

2023

Volltextzugriff (PDF)

Patient-derived organoid (PDO) platforms to facilitate clinical decision making

Journal of translational medicine, 2021-01, Vol.19 (1), p.40-40, Article 40

2021

Volltextzugriff (PDF)

Patient derived organoids in prostate cancer: improving therapeutic efficacy in precision medicine

Molecular cancer, 2021-09, Vol.20 (1), p.125-125, Article 125

2021

Volltextzugriff (PDF)

Exploring Tumor–Immune Interactions in Co-Culture Models of T Cells and Tumor Organoids Derived from Patients

International journal of molecular sciences, 2023-10, Vol.24 (19), p.14609

2023

Volltextzugriff (PDF)

Cancer organoid-based diagnosis reactivity prediction (CODRP) index-based anticancer drug sensitivity test in ALK-rearrangement positive non-small cell lung cancer (NSCLC)

Journal of experimental & clinical cancer research, 2023-11, Vol.42 (1), p.1-309, Article 309

2023

Volltextzugriff (PDF)

1 – 25 von 127

Suche als RSS-Feed

Aktive Filter

ThemaCancer Therapies

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(125)
Mit Volltextzugriff
(125)

Publikationsform

Artikel
(127)

Sprache

Englisch
(127)

Erscheinungsjahr

n.n

Thema

14 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Cancers
(30)
Journal Of Experimental & Clinical Cancer Research
(11)
International Journal Of Molecular Sciences
(9)
Cells
(8)
Advanced Science
(6)
Biomedicines
(5)
Bmc Cancer
(4)
Cancer Cell International
(4)
Cancer Medicine
(3)
Molecular Cancer
(3)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Patient‐Derived Organoids from Colorectal Cancer with Paired Liver Metastasis Reveal Tumor Heterogeneity and Predict Response to Chemotherapy

Establishment of patient‐derived organoids for guiding personalized therapies in breast cancer patients

The lncRNA ‘UCA1’ modulates the response to chemotherapy of ovarian cancer through direct binding to miR‐27a‐5p and control of UBE2N levels

Patient‐derived organoids as a preclinical platform for precision medicine in colorectal cancer

Clinical efficacy of tumor organoid‐guided cancer therapy for locally advanced unresectable or metastatic breast cancer

Patient‐Derived Organoids Can Guide Personalized‐Therapies for Patients with Advanced Breast Cancer

A T Cell‐Engaging Tumor Organoid Platform for Pancreatic Cancer Immunotherapy

Microfluidic Organoid Cultures Derived from Pancreatic Cancer Biopsies for Personalized Testing of Chemotherapy and Immunotherapy

Patient‐Derived Organoids as Therapy Screening Platforms in Cancer Patients

Glutamine metabolism prognostic index predicts tumour microenvironment characteristics and therapeutic efficacy in ovarian cancer

Modelling the tumor immune microenvironment for precision immunotherapy

Genomic characteristics and drug screening among organoids derived from non‐small cell lung cancer patients

Clinical outcomes of EGFR+/METamp+ vs. EGFR+/METamp‐ untreated patients with advanced non‐small cell lung cancer

Enhanced Protein Damage Clearance Induces Broad Drug Resistance in Multitype of Cancers Revealed by an Evolution Drug‐Resistant Model and Genome‐Wide siRNA Screening

Rescue of p53 functions by in vitro‐transcribed mRNA impedes the growth of high‐grade serous ovarian cancer

Preclinical patient‐derived modeling of castration‐resistant prostate cancer facilitates individualized assessment of homologous recombination repair deficient disease

Patient‐derived organoid culture in epithelial ovarian cancers—Techniques, applications, and future perspectives

Recent advances in patient‐derived tumor organoids for reconstructing TME of head and neck cancer

Organoid technology in cancer precision medicine

Butyrate enhances the efficacy of radiotherapy via FOXO3A in colorectal cancer patient‑derived organoids

The functional and clinical roles of liquid biopsy in patient-derived models

Patient-derived organoid (PDO) platforms to facilitate clinical decision making

Patient derived organoids in prostate cancer: improving therapeutic efficacy in precision medicine

Exploring Tumor–Immune Interactions in Co-Culture Models of T Cells and Tumor Organoids Derived from Patients

Cancer organoid-based diagnosis reactivity prediction (CODRP) index-based anticancer drug sensitivity test in ALK-rearrangement positive non-small cell lung cancer (NSCLC)

Aktive Filter

Suchergebnisse filtern